Title: The oral iron chelator deferasirox induces apoptosis in myeloid leukemia cells by targeting caspase.
Journal: Acta haematologica 20110101
Title: Contribution of mast cells to cerebral aneurysm formation.
Journal: Current neurovascular research 20100501
Title: Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
Journal: Acta ophthalmologica 20090801
Title: Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases.
Journal: Expert opinion on pharmacotherapy 20090801
Title: Comparative efficacy of topical antihistamines in an animal model of early phase allergic conjunctivitis.
Journal: Experimental eye research 20080501
Title: Emedastine difumarate inhibits histamine-induced collagen synthesis in dermal fibroblasts.
Journal: Journal of investigational allergology & clinical immunology 20080101
Title: High-performance liquid chromatography-electrospray ionization-mass spectrometric determination of emedastine difumarate in human plasma and its pharmacokinetics.
Journal: Journal of chromatographic science 20070301
Title: [The prompt effect of emedastine eye drop and the safety of its permanent use in children suffering from acute seasonal allergic conjunctivitis].
Journal: Orvosi hetilap 20070211
Title: Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
Journal: European journal of dermatology : EJD 20060101
Title: Estimation of in vivo percutaneous absorption of emedastine from bile excretion data using a deconvolution method.
Journal: Drug metabolism and pharmacokinetics 20051001
Title: Biopharmaceutical considerations on antihistamine effects of topically administered emedastine.
Journal: Journal of pharmaceutical sciences 20050101
Title: [Topical H1 antihistaminics in the therapy of acute conjunctival allergic reactions].
Journal: Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20040101
Title: Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus terfenadine in the treatment of seasonal allergic rhinitis.
Journal: Arzneimittel-Forschung 20040101
Title: Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus cetirizine in the treatment of seasonal allergic rhinitis.
Journal: Arzneimittel-Forschung 20040101
Title: Suplatast tosilate inhibits eosinophil production and recruitment into the skin in murine contact sensitivity.
Journal: Clinical immunology (Orlando, Fla.) 20030901
Title: Development of a new dissolution test method for an oral controlled release preparation, the PVA swelling controlled release system (SCRS).
Journal: Journal of controlled release : official journal of the Controlled Release Society 20030605
Title: [Effects of emedastine eyedrops on acute seasonal allergic conjunctivitis in children].
Journal: Orvosi hetilap 20030406
Title: [In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
Journal: Journal francais d'ophtalmologie 20030401
Title: Epinastine inhibits eosinophil chemotaxis and adhesion molecules in atopic dermatitis.
Journal: Skin pharmacology and applied skin physiology 20030101
Title: Pharmacokinetic and mass balance study of unlabelled and (14)C-labelled emedastine difumarate in healthy volunteers.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20020901
Title: Effect of antiallergic drugs on interleukin 5-induced eosinophil infiltration of rat airways.
Journal: Biological & pharmaceutical bulletin 20020301
Title: Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females.
Journal: Journal of psychopharmacology (Oxford, England) 20020301
Title: Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model.
Journal: Clinical therapeutics 20020301
Title: A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model.
Journal: Clinical therapeutics 20020301
Title: Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-gamma and IL-4 in human keratinocytes.
Journal: Journal of dermatological science 20020101
Title: Comparison of emedastine 0.05% or nedocromil sodium 2% eye drops and placebo in controlling local reactions in subjects with allergic conjunctivitis.
Journal: European journal of ophthalmology 20020101
Title: Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.
Journal: American journal of ophthalmology 20010601
Title: VUF-K-8788, a periphery-selective histamine H1 antagonist with anti-pruritic activities.
Journal: Japanese journal of pharmacology 20010501
Title: Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment.
Journal: European journal of clinical pharmacology 20010301
Title: Emedastine-ketoconazole: pharmacokinetic and pharmacodynamic interactions in healthy volunteers.
Journal: International journal of clinical pharmacology and therapeutics 20010301
Title: Cost effectiveness of emedastine versus levocabastine in the treatment of allergic conjunctivitis in 7 European countries.
Journal: PharmacoEconomics 20010101
Title: Effect of emedastine difumarate on CC chemokine-elicited eosinophil migration.
Journal: International archives of allergy and immunology 20010101
Title: General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 1st communication: effects on the central nervous system.
Journal: Arzneimittel-Forschung 19880101
Title: Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonist.
Journal: Agents and actions 19870201
Title: Sharif NA, et al. Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies. J Ocul Pharmacol. 1994 Winter;10(4):653-64.
Title: Murota H, et al. Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases. Expert Opin Pharmacother. 2009 Aug;10(11):1859-67.
Title: Andoh T, et al. Involvement of blockade of leukotriene B(4) action in anti-pruritic effects of emedastine in mice. Eur J Pharmacol. 2000 Oct 6;406(1):149-52.
